BackHealthequity Overview
Healthequity Inc

Healthequity Return on Equity

Latest ROE for Healthequity: 11.27% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

11.27%

Return on Equity

11.27%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Healthequity (HQY) FAQ

Healthequity (HQY) currently reports a ROE of 11.27%. That is below the Technology sector average of 47.1%. Use the charts on this page to explore Healthequity's ROE history and peer comparisons.

Healthequity's ROE of 11.27% is lower than the Technology sector average of 47.1%. That is roughly 76.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Healthequity's current 11.27% should be judged against Technology norms (sector average: 47.1%) and against HQY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 11.27%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 47.1%. From there, open related valuation or income-statement pages for Healthequity, and consider following HQY for alerts when major investors trade the stock.

Healthequity is classified in the Technology sector. On ROE, it currently shows 11.27% versus a sector average near 47.1%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing HQY with unrelated industries.